患者の脱落を予測する:ヘリコバクター・パイロリ根絶療法後のフォローアップの損失のためのノモグラム
Xiao Zhao1, Xiao She1, Haiyan Yang1
1Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Frontiers in public health
|February 20, 2026
まとめ
新しいノモグラムは,ヘリコバクター・パイロリ根絶中にフォローアップ (LTFU) への患者の損失を予測します. このツールは,この世界的な健康問題に対する治療の成功率を改善することを目的として,高リスクの個人を特定します.
科学分野:
- 胃腸内科 胃腸内科
- 公衆衛生は公衆衛生である.
- 医療情報工学 医療情報工学
背景:
- ヘリコバクター・パイロリ感染症は,特に発展途上国において,世界的な健康問題である.
- H. pyloriの根絶は,胃がんの予防に不可欠ですが,抗生物質耐性およびフォローアップ (LTFU) への患者の損失などの課題に直面しています.
- LTFUは,H. pyloriの根絶治療の成功に重大な影響を及ぼします.
研究 の 目的:
- H. pyloriの根絶後にLTFUに関連した危険因子を特定するために.
- H. pyloriの根絶を受けた患者のLTFUリスクを評価するための予測ノモグラムを開発する.
主な方法:
- 前向きなコホート研究では,これまで治療を受けたことのない患者を対象に実施した.
- LASSO回帰とロジスティック回帰を使用して,LTFUの予測ノモグラムを開発しました.
- モデルの性能は,AUC,校正,および決定曲線分析 (DCA) を使用して検証されました.
主要な成果:
- LTFUの6つの独立した予測要因が特定されました:BMI>30 kg/m2,公務員であること,病院までの距離>10 km,アルコールの消費,より長い外来患者待合時間,およびフォローアップ意識の欠如.
- ノモグラムは,トレーニングセットでは0.885のAUC,テストセットでは0.862のAUCで高い予測精度を達成しました.
- 決定曲線分析は,LTFUリスクを予測する補助ツールとしてのノモグラムの有利な臨床的有用性を示しました.
結論:
- 検証されたノモグラムは,H. pyloriの根絶を受けた患者のLTFUリスクを効果的に予測します.
- この予測ツールは,H. pylori感染の治療管理と治療結果を改善するのに役立ちます.
- 特定された危険因子に対処することで,LTFUを軽減し,根絶の成功率を高めることができます.
さらに関連する動画
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
858
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
1.3K
関連する概念動画
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.5K
01:26Peptic Ulcer Disease IV: Management
548
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
548
01:23Dosage Regimen Designs: Nomograms and Tabulations
234
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
234
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
664
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
664
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
997
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
997
01:23Gastritis III: Clinical Manifestations and Management
1.4K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.4K